Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:36 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 601–624 of 1,410 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Cardiovascular Function Clear all

Conditions: Dementia, Dementia, Vascular, Dementia Alzheimers, Dementia, Mixed, Dementia, Mild, Dementia of Alzheimer Type, Mild Cognitive Impairment, Mild Dementia
Interventions: SmartPrompt smartphone application; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Microvascular Dysfunction
Interventions: Low sodium no cheese, Low sodium cheese, High sodium no cheese, High sodium cheese; Dietary Supplement
Lead sponsor: Lacy Alexander; Other
Eligibility: 55 Years to 75 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: University Park, Pennsylvania

Conditions: Aphasia, Stroke
Interventions: Magstim SuperRapid; Device
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Stroke
Interventions: repetitive Transcranial Magnetic Stimulation -On, repetitive Transcranial Magnetic Stimulation -Off; Device
Lead sponsor: David Chiu, MD; Other
Eligibility: 18 Years to 80 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Chronic Kidney Disease, Cardiovascular Disease
Interventions: Pomegranate extracts; Dietary Supplement
Lead sponsor: Kenneth Wilund; Other
Eligibility: 30 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Champaign, Illinois

Conditions: Coarctation of the Aorta
Interventions: atorvastatin, Sugar pill; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Thrombocytopenia, Myocardial Infarction
Interventions: Aspirin; Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: Not listed
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2008
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stroke, Hemiplegia, Cerebrovascular Accident (CVA), Hemiparesis
Interventions: Contralaterally Controlled Functional Electrical Stimulation, New rTMS approach, Conventional rTMS approach, Sham rTMS approach; Device
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 90 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Endothelial Dysfunction, Vascular Stiffness, Left Ventricular Hypertrophy, Left Ventricular Dysfunction
Interventions: Sodium Reduction Intervention; Behavioral
Lead sponsor: Tulane University; Other
Eligibility: 40 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: New Orleans, Louisiana

Conditions: Wegener Granulomatosis, Microscopic Polyangiitis, Churg-Strauss Syndrome, Polyarteritis Nodosa, Giant Cell Arteritis, Takayasu's Arteritis, Henoch-Schoenlein Purpura, Behcet's Disease, CNS Vasculitis
Interventions: Not listed
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years and older
Enrollment: 707 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: End Stage Renal Disease, Hemodialysis
Interventions: Spironolactone, L-arginine, Placebo; Drug · Dietary Supplement
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 85 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2018
U.S. locations: 3
States / cities: Boston, Massachusetts

Conditions: Type 2 Diabetes
Interventions: Montelukast, Montelukast Placebo; Drug
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 14 Years to 24 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Cerebrovascular Accident
Interventions: Transient deafferentation; Procedure
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: Not listed
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: Northwell Health; Other
Eligibility: 18 Years to 80 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: New Hyde Park, New York

Conditions: Coronary Artery Disease
Interventions: Dual Source Multidetector CT (DSCT) w/ Adenosine enhancement; Radiation
Lead sponsor: Cedars-Sinai Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Ischemic Cardiomyopathy
Interventions: Mesenchymal Stem Cells (MSC), c-kit+ cells, Placebo (Plasmalyte A); Biological
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 21 Years to 79 Years
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 7
States / cities: Stanford, California • Gainesville, Florida • Miami, Florida + 4 more

Conditions: Stroke
Interventions: Conventional High Intensity Gait Training, Standard FES to the Tibialis Anterior (TA), Synergy-Based Multichannel FES (MFES), Muscle Synergy Visual Biofeedback; Device
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years to 18 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Gait Training, Locomotion
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Stroke
Interventions: Electrical stimulation-dynamic hand orthosis; Other
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 20 Years to 85 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Galveston, Texas

Conditions: Coronary Artery Disease
Interventions: Egg supplementation, Egg substitute, Control diet; Dietary Supplement
Lead sponsor: Griffin Hospital; Other
Eligibility: 35 Years to 75 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Derby, Connecticut

Conditions: Stroke
Interventions: Rehabilitation exercise; Behavioral
Lead sponsor: University of Kansas; Other
Eligibility: 18 Years to 85 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Congenital Heart Disease, Neurodevelopment, Executive Function, Working Memory Training, Infant Open-heart Surgery
Interventions: Cogmed Working Memory Training; Behavioral
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 13 Years to 16 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Improve Endothelial Function and Decrease Vascular Stenosis
Interventions: Sildenafil, Placebo; Drug · Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years to 99 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Obesity, Vascular Dementia, Cognitive Impairment
Interventions: Urolithin A, Placebo; Dietary Supplement · Other
Lead sponsor: University of Oklahoma; Other
Eligibility: 40 Years to 64 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Search by objective public record fields.

Feasibility of the SmartPrompt for Improving Everyday Function in Dementia

Cheese Consumption and Human Microvascular Function

Post-Stroke Aphasia and Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment Study

Multifocal Brain Magnetic Stimulation in Chronic Ischemic Stroke

Pomegranate Supplementation on Physical Function and Cardiovascular Disease Risk in CKD Patients

Statins and Endothelial Function in Patients With Coarctation of the Aorta

Aspirin in Patients With Myocardial Infarction and Thrombocytopenia

rTMS Plus CCFES-mediated Functional Task Practice for Severe Stroke

Sodium Lowering Vascular Effects Trial

Vasculitis Illness Perception (VIP) Study

L-Arginine and Spironolactone Trial in Dialysis-Dependent ESRD

SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes

Ischemic Nerve Block to Improve Hand Function in Stroke Patients

The Study Of CT Scans and Echo Parameters in Patients With PAH

Adenosine Dual Source Computed Tomography (CT) Versus Adenosine Single Photon Emission Computed Tomography (SPECT)

Combination of Mesenchymal and C-kit+ Cardiac Stem Cells as Regenerative Therapy for Heart Failure

Muscle Coordination-Based Feedback for Stroke Rehabilitation

Gait Training and Brain Changes in Stroke Patients

Electrical Stimulation and a Dynamic Orthosis for Stroke Recovery

Effects of Egg Ingestion on Endothelial Function in Adults With Coronary Artery Disease

The Effect of Aerobic Exercise on Learning After Stroke

Improving Neurodevelopment in Adolescents With Congenital Heart Disease

Phosphodiesterase Type 5 Inhibition to Improve Endothelial Function and Vascular Remodeling in Chronic Kidney Disease and End Stage Renal Disease Patients Requiring New Arteriovenous Fistula

Urolithin A Supplementation in Middle-aged Adults With Obesity